He graduated from the University of Rome “La Sapienza” and obtained his PhD in “Technological Applications in Hematology” at the Università Cattolica del Sacro Cuore, where he pursued both training and professional activities from 2004 to 2016. From 2013 to 2019, he taught in the “Hematology Specialization Program” at the Università Cattolica del Sacro Cuore. Since 2016, he has been teaching in the Bachelor’s Degree program in “Medical Biotechnology” at the University of Rome “Tor Vergata,” where he also continues his research activities within the Department of Biomedicine and Prevention. Since 2019, he has been teaching Hematology and Laboratory Medicine Technical Sciences at Unicamillus – Saint Camillus International University of Health Sciences in Rome, Italy, where he also serves as coordinator of the Integrated Course in Medical Oncology and Blood Disorders. His research has consistently focused on the study of myeloid neoplasms, both de novo and therapy-related. His main research areas include: The mutational landscape and epigenetic of Myelodysplastic Syndromes and Acute Myeloid Leukemias, both de novo and therapy-related (t-MN). The role of polymorphisms as risk and prognostic factors in Myelodysplastic Syndromes, Acute Myeloid Leukemias and t-MN. Identification of predictive markers of response in myeloid neoplasms. Characterization of the bone marrow tumor microenvironment.